spacer
home > pmps > winter 2003 > take the hassle out of buying a vessel
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Take the Hassle Out of Buying a Vessel

Purchasing new process vessels for the pharmaceutical industry is often a time-consuming and onerous task. The industry is required to ensure that their new equipment meets with current legislation, operating procedures and approvals, as well as ensuring that any ancillary equipment is fully integrated for successful operation.

For process engineers wishing to purchase a new vessel there are a number of procedures to go through before a vessel and any ancillary equipment is fully operational. These procedures can be very time consuming, and if not administered correctly can create unnecessary delays and hassle. This article breaks these procedures down into categories and also indicates the best methods that engineers should adopt when purchasing new vessels.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Paul Mayer, Sales Director at Braby

A qualified Mechanical Engineer, Paul Mayer's first position was as a Production Engineer in a large UK print engineering company. He soon progressed to managing the production area responsible for the co-ordination of the entire plant manufacturing process. After several years, and following a period of skills training, Paul assumed the role of Commercial Manager for the same organisation working with a large international customer base. This lead to his appointment as Head of the sales force, which covered most of the world market. Paul joined Braby in 1997 and managed the sales force becoming Director of Sales and Marketing. He and his team have lead Braby into many new market areas and developed the single source approach for prospective customers.

spacer
Paul Mayer
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Hansa Biopharma initiate a new Contract Development and Manufacturing project in immunological diseases

Vilnius, Lithuania, and Lund, Sweden - December 20th, 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced a new service agreement to develop the next generation of IgG cleaving enzymes.
More info >>

White Papers

7 Common Myths about QP Training Debunked: A Guide for Senior Managers

RSSL

The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >>

 
Industry Events

Clinical Trial Supply Europe

11-12 March 2020, Madrid, Spain

The 21st annual edition promises to grow on the success of 2019’s excellent conference which saw delegates from Europe’s largest pharmaceutical companies and biotech innovators come together to discuss, debate and unpack the latest trends in clinical supply chain innovation. 2020 will offer delegates the opportunity to address the growing need for agility within the supply chain in response to increasingly complex trial demands. With a stream dedicated to supply operations and another to innovative uses of technology in the supply chain, delegates will get the chance to gain practical take-aways that they can apply to their own studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement